Lung Cancers Terminated Phase 2 Trials for Gefitinib (DB00317)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02025218Iressa Re-challenge in Advanced NSCLC EGFR-mutated PatientsTreatment
NCT01405846Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to GefitinibTreatment